Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 67
Filtrar
1.
Cancer Res ; 59(15): 3682-8, 1999 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-10446982

RESUMEN

Previous work showed that the DNA double-strand cleaving agents bleomycin and neocarzinostatin were more mutagenic in plateau-phase than in log-phase cells. To determine whether topoisomerase II poisons that produce double-strand breaks by trapping of cleavable complexes would, likewise, induce mutations specific to plateau-phase cells, aprt mutations induced by amsacrine in both log-phase and plateau-phase CHO cells were analyzed. The maximum aprt mutant frequencies obtained were 7 x 10(-6) after treatment with 0.02 microM amsacrine in log phase and 27 x 10(-6) after treatment with 1 microM amsacrine in plateau phase, compared with a spontaneous frequency of < 1 x 10(-6). Base substitutions dominated the spectrum of mutations in log-phase cells, but were much less prevalent in plateau-phase cells. Both spectra also included small deletions, insertions and duplications, as well as few large-scale deletions or rearrangements. About 5% of the log-phase mutants and 16% of the plateau-phase mutants were +1 frameshifts, and all but one of these were targeted to potential free 3' termini of cleavable complexes, as determined by mapping of cleavage sites in DNA treated with topoisomerase II plus amsacrine in vitro. Thus, these insertions may arise from templated extension of the exposed 3' terminus by a DNA polymerase, followed by resealing of the strand, as shown previously for acridine-induced frameshifts in T4 phage.


Asunto(s)
Amsacrina/farmacología , Células CHO/efectos de los fármacos , ADN-Topoisomerasas de Tipo II/metabolismo , ADN/metabolismo , Inhibidores Enzimáticos/farmacología , Mutación del Sistema de Lectura , Mutagénesis , Adenina Fosforribosiltransferasa/genética , Animales , Secuencia de Bases , División Celular , Cricetinae , ADN/efectos de los fármacos , Exones/genética , Genes/efectos de los fármacos , Datos de Secuencia Molecular , Eliminación de Secuencia , Especificidad por Sustrato , Inhibidores de Topoisomerasa II
2.
Cancer Res ; 50(23): 7527-31, 1990 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-2174727

RESUMEN

The base and sequence specificity of mutagenesis by the carcinogenic antitumor agent melphalan (L-phenylalanine mustard) was examined by in vitro treatment of the plasmid pZ189 followed by replication in human 293 cells, rescue in bacteria, and sequence analysis of mutations in the supF gene. Melphalan was strongly mutagenic in this assay. The induced mutations were predominantly base substitutions, with a minor component of small deletions (3-80 base pairs). Surprisingly, A.T----T.A transversions were by far the most frequent substitutions, suggesting that modifications of adenine may play a major role in mutagenesis. More than half the substitutions were clustered in a C-T-A-A sequence in the anticodon loop. No base substitutions were detected at G-N-C sequences, which are thought to be potential sites of DNA interstrand cross-links. The results raise the possibility that the cytotoxic and mutagenic effects of melphalan may be separable.


Asunto(s)
Vectores Genéticos/efectos de los fármacos , Melfalán/farmacología , Mutagénesis/efectos de los fármacos , Virus 40 de los Simios , Secuencia de Bases , ADN/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Humanos , Datos de Secuencia Molecular , Transfección
3.
Cancer Res ; 54(7): 1707-14, 1994 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-7511048

RESUMEN

The present studies were undertaken to characterize further the potential role of protein kinase C (PKC) in the regulation of apoptosis in HL-60 promyelocytic leukemia cells. The capacity of acute exposure to specific and nonspecific pharmacological inhibitors of PKC to promote apoptotic DNA fragmentation was examined both quantitatively and qualitatively and correlated with effects on cellular differentiation and proliferation. Incubation of HL-60 cells for 6 h with chelerythrine and calphostin C (highly specific inhibitors that act at the regulatory domain) or H7 and gossypol (nonspecific inhibitors that act at the PKC catalytic domain) produced concentration-dependent increases in DNA fragmentation. Induction of DNA fragmentation by chelerythrine, calphostin C, and gossypol was biphasic, resulting in a sharp decline in effect at concentrations above 5 microM, 0.1 microM, and 100 microM, respectively, whereas maximal and more stable effects were observed in response to H7 (100 microM). A 6-h exposure to staurosporine, a nonspecific but potent PKC inhibitor, failed to induce DNA fragmentation at concentrations generally used to achieve maximal inhibition of enzyme activity (e.g., 50 nM) but promoted fragmentation at considerably higher concentrations (e.g., > or = 200 nM). In contrast, 6-h exposures to the nonspecific protein kinase inhibitor hypericin (0.1 to 100 microM) or to the nonspecific inhibitor of protein kinase A, HA1004 (50 microM), were without effect on DNA fragmentation. DNA obtained from cells exposed to chelerythrine (5 microM), calphostin C (100 nM), H7 (50 microM), gossypol (50 microM), and staurosporine (200 nM)--but not hypericin (25 microM)--exhibited clear evidence of internucleosomal DNA cleavage on agarose gel electrophoresis; moreover, these cells exhibited the classical morphological features of apoptosis (cell shrinkage, nuclear condensation, and the formation of apoptotic bodies). All of the PKC inhibitors that induced apoptosis, and one of the inhibitors that did not (hypericin), substantially inhibited HL-60 cell clonogenicity at the concentrations evaluated. None of the agents tested induced cellular maturation as assessed by nonspecific esterase and nitro-blue tetrazolium positivity. DNA fragments obtained from cells exposed to specific and nonspecific PKC inhibitors possessed predominantly 5'-phosphate termini, consistent with the action of a Ca(2+)-/Mg(2+)-dependent endonuclease. Finally, Northern blot analysis revealed that exposure to calphostin C at a concentration that induced apoptosis (100 nM) failed to alter expression of bcl-2, an oncogene known to block apoptosis in both lymphoid and myeloid leukemia cells.(ABSTRACT TRUNCATED AT 400 WORDS)


Asunto(s)
Antineoplásicos/toxicidad , Apoptosis/efectos de los fármacos , Daño del ADN , ADN de Neoplasias/efectos de los fármacos , Inhibidores Enzimáticos/toxicidad , Naftalenos , Proteína Quinasa C/antagonistas & inhibidores , 1-(5-Isoquinolinesulfonil)-2-Metilpiperazina , Alcaloides/toxicidad , Antracenos , Benzofenantridinas , Diferenciación Celular/efectos de los fármacos , Línea Celular , Proteínas Quinasas Dependientes de AMP Cíclico/antagonistas & inhibidores , Gosipol/toxicidad , Humanos , Isoquinolinas/toxicidad , Leucemia Promielocítica Aguda , Perileno/análogos & derivados , Perileno/toxicidad , Fenantridinas/toxicidad , Piperazinas/toxicidad , Compuestos Policíclicos/toxicidad , Estaurosporina , Factores de Tiempo , Células Tumorales Cultivadas
4.
Cancer Res ; 57(21): 4699-702, 1997 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-9354424

RESUMEN

Among the aprt mutations induced in confluence-arrested Chinese hamster ovary D422 cells by the topoisomerase II poison amsacrine, there was a reciprocal exchange between the aprt gene and an unrelated sequence, accompanied by a chromosomal translocation at the aprt locus. The breakpoints in both parental sequences were hot spots for amsacrine-stimulated DNA cleavage in vitro, and the novel junctions formed were precisely as expected for a mechanism involving reciprocal exchange of topoisomerase II subunits followed by resealing of the breaks and correction of mismatches in the cohesive ends. The results are consistent with a role for direct subunit exchange in the production of chromosomal translocations by topoisomerase poisons, although more complex models involving double-strand breakage and repair could produce reciprocal exchanges of similar specificity.


Asunto(s)
Adenina Fosforribosiltransferasa/genética , ADN-Topoisomerasas de Tipo II/genética , Reordenamiento Génico/genética , Eliminación de Secuencia , Translocación Genética , Amsacrina/farmacología , Animales , Antineoplásicos/farmacología , Secuencia de Bases , Células CHO/efectos de los fármacos , Mapeo Cromosómico , Cricetinae , Datos de Secuencia Molecular
5.
Cancer Res ; 53(15): 3547-54, 1993 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-8339261

RESUMEN

In the MCF-7 breast tumor cell line, induction of bulk damage to DNA (measured either as total strand breaks or as double-strand breaks) fails to correspond with the antiproliferative activity of the demethylepipodo-phyllotoxin derivative, VM-26. In contrast, VM-26 produces an early (within 2-3 h) concentration-dependent reduction in c-myc expression (and of DNA synthesis) which parallels inhibition of cell growth, suggesting the possibility of effects of VM-26 at the level of genomic regions which regulate DNA replicative function. Although VM-26 also produces a reduction in c-myc expression in K562 human leukemic cells, these alterations fail to correspond with the concentration-dependent effects on cell growth in this cell line. Utilizing the newly developed alkaline unwinding/Southern blotting assay in the MCF-7 breast tumor cell line, it was determined that VM-26 induces damage within regions surrounding the c-myc gene and the beta-globin gene which exceeds that induced in both alpha-satellite DNA and in L1 repeat sequences; damage within c-myc and beta-globin also exceeds that observed throughout the genome as a whole. These findings indicate that certain genomic regions incur preferential damage in MCF-7 cells exposed to VM-26. It appears possible that damage within such genomic regions could lead to alterations in expression of select genes associated with regulation of cellular proliferation, resulting in reduced DNA synthesis, compromised cell growth, and, ultimately, cell death.


Asunto(s)
Neoplasias de la Mama/genética , Daño del ADN , ADN de Neoplasias/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Tenipósido/farmacología , Southern Blotting , Neoplasias de la Mama/patología , División Celular/efectos de los fármacos , ADN de Neoplasias/biosíntesis , Femenino , Genes myc , Humanos , ARN Neoplásico/biosíntesis , Células Tumorales Cultivadas
6.
Biochim Biophys Acta ; 432(3): 267-72, 1976 May 19.
Artículo en Inglés | MEDLINE | ID: mdl-1268255

RESUMEN

After unifilar substitution of thymine with bromouracil in either human HeLa or bovine cells, exposure to 313 nm light inhibits initiation of clusters of replicons. Since this treatment results in damage only to DNA and because the effect is the same as observed after 100-1000 rads of X-ray irradiation to the same cells, we infer that the effect of the later treatment is also mediated almost exclusively by DNA damage.


Asunto(s)
Bromodesoxiuridina/farmacología , Replicación del ADN/efectos de la radiación , Efectos de la Radiación , Rayos Ultravioleta , Línea Celular , Relación Dosis-Respuesta en la Radiación , Células HeLa/efectos de los fármacos , Células HeLa/metabolismo , Células HeLa/efectos de la radiación , Peso Molecular , Timidina/metabolismo
7.
Biochim Biophys Acta ; 521(1): 126-33, 1978 Nov 21.
Artículo en Inglés | MEDLINE | ID: mdl-82451

RESUMEN

DNA was treated with bleomycin in the presence of Fe2+ and 2-mercaptoethanol under conditions where only a few percent of the bases were released. Release of all four bases was a linear function of bleomycin concentration, but the amount of thymine released was twice that of cytosine, 7 times that of adenine, and twelve times that of guanine. Unidentified minor products of thymine, of cytosine and of a purine were also released. Bromouracil did not sensitize DNA to bleomycin-induced breakage, and was released at the same rate as thymine.


Asunto(s)
Bleomicina , ADN Bacteriano , Fenómenos Químicos , Química , Escherichia coli , Hierro , Cinética , Mercaptoetanol , Purinas/análisis , Pirimidinas/análisis
8.
J Mol Biol ; 229(1): 52-66, 1993 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-8380617

RESUMEN

Sixty-five teniposide-induced mutations at the hemizygous aprt locus of CHO D422 cells were analyzed by polymerase chain reaction and DNA sequencing. Most (63%) of the mutations were deletions, duplications and insertions of various sizes, with the majority being less than 20 base-pairs. The remaining mutations were base substitutions, the majority of which were transversions. A significant correspondence was found between the teniposide-induced small deletion/duplication mutations and sites of teniposide-stimulated DNA strand cleavage by topoisomerase II in vitro. In particular, sequences which were deleted in one or more of the mutants showed a much higher incidence of strong cleavage sites than sequences not involved in deletions. However, the exact positioning of the cleavage sites with respect to the deletion termini was variable. The data did not suggest any unified model to account for all the mutations, but most of the deletions and duplications could be accounted for by one of three mechanisms: (1) double-strand break repair nonhomologous end-joining; (2) replication slippage/misalignment; and (3) addition or deletion of a few nucleotides at free 3' ends left by topoisomerase II, as previously suggested for similar mutations in phage T4. There was no evidence that topoisomerase II subunit exchange was a significant mechanism of mutagenesis in this system.


Asunto(s)
ADN/efectos de los fármacos , Mutágenos/farmacología , Tenipósido/farmacología , Inhibidores de Topoisomerasa II , Animales , Secuencia de Bases , Células CHO , Cricetinae , Modelos Genéticos , Datos de Secuencia Molecular , Mutagénesis Insercional , Eliminación de Secuencia
9.
J Mol Biol ; 243(2): 216-26, 1994 Oct 21.
Artículo en Inglés | MEDLINE | ID: mdl-7523683

RESUMEN

One possible mechanism for the generation of deletion mutations is inaccurate repair of DNA double-strand breaks. In an attempt to detect such aberrant repair events in intact cells, confluent stationary phase cultures of chinese hamster ovary D422 cells, which are hemizygous for aprt, were treated for two days with low concentrations of bleomycin, and aprt mutant clones were selected and analyzed by polymerase chain reaction and DNA sequencing. Bleomycin was quite mutagenic in stationary phase cells, increasing the mutant frequency by five to 40-fold at 5 to 50% survival. While spontaneous mutations generated under these conditions were predominantly base substitutions, the majority of the bleomycin-induced mutations were very small deletions, with lesser numbers of large deletions/rearrangements and base substitutions. Although the small deletions tended to be clustered in several short segments of the gene, nucleosome positioning studies indicated that there was no consistent phasing of nucleosomes in aprt, suggesting that the clustering was due to sequence specificity rather than chromatin structure. About half of the bleomycin-induced mutations were single-base-pair (-1) deletions, and the majority of these involved deletion of one C in a G-Cn sequence (n > or = 2). At such sites, bleomycin is known to induce double-strand breaks by fragmentation of deoxyribose moieties at the same sequence position in both strands, resulting in a blunt-ended double-strand break with 5'-phosphate and 3'-phosphoglycolate termini. Thus, this sequence specificity is consistent with a model in which bleomycin-induced -1 deletions are generated by a double-strand break rejoining process involving removal of phosphoglycolate moieties from both 3' ends, followed by blunt-end ligation. The results support the view that repair of free radical-mediated double-strand breaks in mammalian cells in G1/G0 phase can be effected by such simple end-joining mechanisms, without the need for homologous recombination.


Asunto(s)
Adenina Fosforribosiltransferasa/genética , Bleomicina/farmacología , Reparación del ADN/fisiología , Fase G1/genética , Fase de Descanso del Ciclo Celular/genética , Eliminación de Secuencia/efectos de los fármacos , Animales , Secuencia de Bases , Células CHO , Cricetinae , Cricetulus , Modelos Genéticos , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Mutación , Nucleosomas/genética
10.
Int J Radiat Biol ; 81(6): 445-58, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16308915

RESUMEN

Ionizing radiation has been reported to promote accelerated or premature senescence in both normal and tumour cell lines. The current studies were designed to characterize the accelerated senescence response to radiation in the breast tumour cell in terms of its dependence on functional p53 and its relationship to telomerase activity, telomere lengths, expression of human telomerase reverse transcriptase (hTERT, the catalytic subunit of telomerase) and human telomerase RNA (hTR, the RNA subunit of telomerase), as well as the induction of cytogenetic aberrations. Studies were performed in p53 wild-type MCF-7 cells, MCF-7/E6 cells with attenuated p53 function, MDA-MB231 cells with mutant p53 and MCF-7/hTERT cells with constitutive expression of hTERT. Telomerase activity was measured by the telomeric repeat amplification protocol (TRAP assay), telomere lengths by the terminal restriction fragment (TRF) assay, hTR and hTERT expression by reverse transcriptase-polymerase chain reaction (RT-PCR), senescence by beta-galactosidase staining, and apoptosis by TdT-mediated d-UTP-X nick-end labelling (TUNEL assay). Widespread and extensive expression of beta-galactosidase, a marker of cellular senescence, was evident in MCF-7 breast tumour cells following exposure to 10 Gy of ionizing radiation. Radiation did not suppress expression of either hTERT or hTR, alter telomerase activity or induce telomere shortening. Senescence arrest was also observed in irradiated MCF-7/hTERT cells, which have elongated telomeres due to the ectopic expression of the catalytic component of telomerase. In contrast to MCF-7 cells, irradiated MDA-MB231 breast tumour cells and MCF-7/E6 cells failed to senesce and instead demonstrated a delayed apoptotic cell death. Irradiation produced chromosome end associated abnormalities, including end-to-end fusions (an indicator of telomere dysfunction) in MCF-7 cells, MCF-7/hTERT cells, as well as in MCF-7/E6 cells. When cells were maintained in culture following irradiation, proliferative recovery was evident exclusively after senescence while the cell lines which responded to radiation by apoptosis continued to decline in cell number. Accelerated senescence in response to ionizing radiation is p53 dependent and associated with telomer dysfunction but is unrelated to changes in telomerase activity or telomere lengths, expression of hTERT and hTR. In the absence of functional p53, cells are unable to arrest for an extended period, resulting in apoptotic cell death while accelerated senescence in cells expressing p53 is succeeded by proliferative recovery.


Asunto(s)
Neoplasias de la Mama/radioterapia , Senescencia Celular/efectos de la radiación , Proteína p53 Supresora de Tumor/fisiología , Apoptosis/efectos de la radiación , Neoplasias de la Mama/genética , Neoplasias de la Mama/patología , Ciclo Celular/efectos de la radiación , Línea Celular Tumoral , Aberraciones Cromosómicas , Proteínas de Unión al ADN/metabolismo , Femenino , Humanos , ARN/análisis , Telomerasa/análisis , Telomerasa/metabolismo , Telómero
11.
Biochimie ; 69(8): 815-23, 1987 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-2447954

RESUMEN

The anti-tumor antibiotics neocarzinostatin and bleomycin specifically oxidize deoxyribose in DNA at the C-5' and C-4' positions, respectively. The resulting DNA lesions include strand breaks and apyrimidinic sites. Both agents are broad specificity mutagens, inducing, in various systems, base substitutions, frameshifts and deletions. Sequencing studies in bacterial systems have suggested that the base substitutions may result primarily from replicative bypass of the oxidized apyrimidinic sites.


Asunto(s)
Antibióticos Antineoplásicos/toxicidad , Bleomicina/toxicidad , ADN/metabolismo , Mutágenos , Cinostatina/toxicidad , Animales , Oxidación-Reducción
12.
Biochem Pharmacol ; 50(8): 1317-9, 1995 Oct 12.
Artículo en Inglés | MEDLINE | ID: mdl-7488252

RESUMEN

Previous studies with MCF-7 cells demonstrated that several agents induce greater strand breakage in active genes than in nontranscribed centromeric regions. To better assess the effects of gene activity and inactivity, an allele-specific DNA strand break assay was developed, which allowed direct comparison of damage at a specific genetic locus on the active and inactive X chromosomes. The ZP lymphoblastoid cell line is heterozygous at the glucose-6-phosphate dehydrogenase (G6PD) locus, and the unexpressed (A) allele on the inactive X chromosome contains a FokI restriction site that is lacking in the expressed (B) allele on the active X. ZP cells were treated with camptothecin or amsacrine, and subjected to alkaline-induced DNA unwinding. Following detergent lysis and digestion of single-stranded DNA with S1 nuclease, the remaining double-stranded DNA was isolated and subjected to polymerase chain reaction (PCR) with primers that flank the polymorphic FokI site, with [alpha-32P]dCTP being added in the last PCR cycle. The resulting labeled PCR product was cleaved with FokI to assess the A/B allele ratio in the double-stranded DNA fraction. Treatment with camptothecin and amsacrine increased the apparent A/B ratio by factors of 2-3 and 1.5-2 respectively, indicating that the active B allele is preferentially damaged by these agents.


Asunto(s)
Alelos , Antineoplásicos Fitogénicos/farmacología , Camptotecina/farmacología , Linfocitos/efectos de los fármacos , Cromosoma X/efectos de los fármacos , Amsacrina/farmacología , Secuencia de Bases , Línea Celular Transformada , ADN/aislamiento & purificación , Daño del ADN , Técnicas Genéticas , Glucosafosfato Deshidrogenasa/genética , Humanos , Concentración de Iones de Hidrógeno , Linfocitos/ultraestructura , Datos de Secuencia Molecular
13.
Biochem Pharmacol ; 47(2): 317-29, 1994 Jan 20.
Artículo en Inglés | MEDLINE | ID: mdl-8304976

RESUMEN

In the MCF-7 human breast tumor cell line, the aminoacridine, m-AMSA, induces protein-associated DNA strand breaks consistent with inhibition of topoisomerase II. However, neither single-strand nor double-strand breaks in DNA, determined using conventional assays, show a consistent relationship with m-AMSA-induced inhibition of growth. In contrast, when DNA strand breaks are determined by alkaline unwinding under the high salt conditions of the alkaline unwinding/Southern blotting (AU/SB) assay, developed by our laboratories, damage to DNA corresponds closely with growth inhibition. The AU/SB assay, which is capable of assessing breaks within large-scale domains (upwards of 1 megabase) surrounding genes of interest, was further utilized to explore the capacity of m-AMSA to induce damage within specific genomic regions that may regulate cell growth. Regions encompassing the transcriptionally active oncogenes, c-myc and c-fos, were found to be more susceptible to m-AMSA-induced strand breaks than the region encompassing the non-transcribed alpha-satellite DNA or the genome as a whole (bulk DNA). These findings demonstrate that m-AMSA may produce more pronounced damage within specific genomic regions than in bulk DNA, m-AMSA also preferentially altered expression of the c-myc oncogene; at an m-AMSA concentration where growth was inhibited by between 70 and 80%, steady-state c-myc mRNA levels declined to approximately 10-15% of control levels within 2-3 hr; furthermore, concentration-dependent reductions in c-myc expression appeared to coincide with growth inhibition. In addition, inhibition of [3H]thymidine incorporation after 2 hr directly paralleled inhibition of growth, suggesting an early effect at the level of DNA biosynthesis, possibly related to the down-regulation of c-myc expression. It is proposed that specific lesions, e.g., in regions surrounding the c-myc gene, as well as generalized lesions in DNA may lead to growth inhibition mediated by down-regulation of the expression of select growth regulatory genes, such as c-myc.


Asunto(s)
Amsacrina/farmacología , Daño del ADN , ADN/efectos de los fármacos , División Celular/efectos de los fármacos , ADN Satélite/efectos de los fármacos , ADN de Cadena Simple/efectos de los fármacos , Regulación hacia Abajo , Expresión Génica/efectos de los fármacos , Genes myc/efectos de los fármacos , Humanos , ARN Mensajero/análisis , Células Tumorales Cultivadas/efectos de los fármacos
14.
Biochem Pharmacol ; 47(5): 839-52, 1994 Mar 02.
Artículo en Inglés | MEDLINE | ID: mdl-8135859

RESUMEN

We have demonstrated previously that bryostatin 1, a macrocylic lactone with putative protein kinase C (PKC)-activating properties, synergistically augments the antileukemic actions of the deoxycytidine analog 1-[beta-D-arabinofuranosyl]cytosine (ara-C) in HL-60 human promyelocytic leukemia cells (Grant et al., Biochem Pharmacol 42: 853-867, 1991), and that this effect appears to be related to sensitization to ara-C-induced apoptosis (Grant et al., Cancer Res 52: 6270-6278, 1992). In the present studies, we have assessed the extent of this damage by quantitative spectrofluorophotometry of small molecular weight, double-stranded DNA fragments in order to provide: (a) a more complete characterization of the interaction between ara-C and bryostatin 1, and (b) a direct comparison of the relative effects of bryostatin 1 treatment with other pharmacological manipulations known to modulate protein kinase C activity. Exposure of cells to ara-C (10(-9) to 10(-4) M; 1-24 hr) induced time- and concentration-related increases in the extent of DNA fragmentation. Treatment with bryostatin 1 (10(-11) to 10(-7) M; 1-24 hr) alone failed to induce DNA damage, but promoted substantial time- and concentration-related increases in the extent of fragmentation induced by a subsequent 6-hr exposure to ara-C. Maximal potentiation of fragmentation (e.g. 2- to 3-fold greater than that obtained with ara-C alone) was observed following a 24-hr pretreatment with 10(-8) M or 10(-7) M bryostatin 1, and correlated closely with enhanced inhibition of HL-60 cell clonogenicity. The stage-1 tumor-promoter phorbol dibutyrate potentiated the effects of ara-C in a biphasic manner, maximally augmenting the response at 2.5 x 10(-8) M, but exerting no effect at 10(-7) M, whereas the stage-2 tumor-promoter mezerein failed to augment ara-C-related DNA fragmentation at low concentrations, and antagonized ara-C action at high concentrations. In contrast, ara-C-related DNA fragmentation was attenuated or abolished either by continual preexposure to synthetic diglyceride or by pretreatment with exogenous phospholipase C at all concentrations tested. Increased DNA fragmentation was not specifically related to recruitment of cells into S-phase or enhancement of ara-C-related cellular differentiation. Finally, concentrations of bryostatin 1 that maximally potentiated ara-C-related DNA fragmentation were associated with virtually complete down-regulation of total cellular PKC activity, whereas diglyceride and phospholipase C, which suppressed the response to ara-C, moderately increased total PKC activity.(ABSTRACT TRUNCATED AT 400 WORDS)


Asunto(s)
Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Daño del ADN , ADN de Neoplasias/efectos de los fármacos , Lactonas/farmacología , Leucemia Mieloide/genética , Proteína Quinasa C/efectos de los fármacos , Antineoplásicos/administración & dosificación , Apoptosis/genética , Brioestatinas , Citarabina/administración & dosificación , Citarabina/farmacología , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Humanos , Lactonas/administración & dosificación , Leucemia Mieloide/tratamiento farmacológico , Leucemia Mieloide/patología , Macrólidos , Proteína Quinasa C/análisis , Células Tumorales Cultivadas
15.
Biochem Pharmacol ; 58(1): 121-31, 1999 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-10403525

RESUMEN

Events accompanying sequential exposure of U937 leukemic cells to the deoxycytidine (dCyd) analogs 1-[beta-D-arabinofuranosyl]cytosine (ara-C) or 2',2'-difluorodeoxycytidine (gemcitabine; dFdC) followed by two protein kinase C (PKC) activators [bryostatin 1 (BRY) or phorbol 12'-myristate 13'-acetate (PMA)] exhibiting disparate differentiation-inducing abilities were characterized. A 24-hr exposure to 10 nM BRY or PMA after a 6-hr incubation with 1 microM ara-C or 100 nM dFdC resulted in equivalent increases in apoptosis, caspase-3 activation, and polyADP-ribose polymerase degradation, as well as identical DNA cleavage patterns. BRY and PMA did not modify retention of the lethal ara-C metabolite ara-CTP or alter ara-CTP/dCTP ratios. Unexpectedly, pretreatment of cells with ara-C or dFdC opposed BRY- and PMA-related induction of the cyclin-dependent kinase inhibitors (CDKIs) p21CIP1 and/or p27KIP1. These effects were not mimicked by the DNA polymerase inhibitor aphidicolin or by VP-16, a potent inducer of apoptosis. Inhibition of PKC activator-induced CDKI expression by ara-C and dFdC did not lead to redistribution of proliferating cell nuclear antigen but was accompanied by sub-additive or antagonistic effects on leukemic cell differentiation. Sequential exposure of cells to ara-C followed by BRY or PMA led to substantial reductions in clonogenicity that could not be attributed solely to apoptosis. Finally, pretreatment of cells with ara-C attenuated PMA- and BRY-mediated activation of mitogen-activated protein kinase, an enzyme implicated in CDKI induction. Collectively, these findings suggest that pretreatment of leukemic cells with certain dCyd analogs interferes with CDKI induction by the PKC activators PMA and BRY, and that this action may contribute to modulation of apoptosis and differentiation in cells exposed sequentially to these agents.


Asunto(s)
Proteínas de Ciclo Celular , Ciclinas/biosíntesis , Citarabina/farmacología , Desoxicitidina/análogos & derivados , Lactonas/farmacología , Leucemia/metabolismo , Proteínas Asociadas a Microtúbulos/biosíntesis , Proteína Quinasa C/metabolismo , Acetato de Tetradecanoilforbol/farmacología , Proteínas Supresoras de Tumor , Antimetabolitos Antineoplásicos/farmacología , Apoptosis , Brioestatinas , Diferenciación Celular/efectos de los fármacos , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Inhibidor p27 de las Quinasas Dependientes de la Ciclina , Desoxicitidina/farmacología , Interacciones Farmacológicas , Activación Enzimática , Humanos , Lactonas/antagonistas & inhibidores , Leucemia/tratamiento farmacológico , Leucemia/patología , Macrólidos , Mitógenos/farmacología , Acetato de Tetradecanoilforbol/antagonistas & inhibidores , Células U937 , Gemcitabina
16.
Radiat Res ; 148(1): 22-8, 1997 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9216614

RESUMEN

Two of the enzymes involved in the response of mammalian cells to ionizing radiation are the DNA-dependent protein kinase and poly(ADP-ribose) polymerase. These enzymes are known to be activated by binding to DNA strand breaks, but previous studies designed to look at strand break specificity have employed enzymatically generated strand breaks and not irradiated DNA. Using highly purified DNA-dependent protein kinase, we compared enzyme activation by a series of DNA substrates. Irradiated plasmid DNA activated DNA-dependent protein kinase in a dose-dependent manner. When calculated in terms of the molar concentration of double-strand breaks, the enzyme activation by irradiated DNA was comparable to that by restriction enzyme-cleaved DNA. Linear DNA purified after plasmid irradiation also activated DNA-dependent protein kinase to a comparable extent, but nicked DNA, either isolated from irradiated plasmid or generated by DNase I, failed to activate the enzyme. A comparison of the enzyme activation by plasmid molecules with different 3'- and 5'-terminal groups indicated that the chemical nature of the DNA termini at the double-strand break does not significantly influence the response of the DNA-dependent protein kinase. Similar experiments with poly(ADP-ribose) polymerase demonstrated that single- and double-strand breaks activate this enzyme with almost equal efficiency, but because of their greater number, single-strand breaks dominate the response of poly(ADP-ribose) polymerase to irradiated DNA.


Asunto(s)
Daño del ADN/efectos de la radiación , Fragmentación del ADN , Reparación del ADN , ADN Bacteriano/efectos de la radiación , Proteínas de Unión al ADN , Poli(ADP-Ribosa) Polimerasas/metabolismo , Proteínas Serina-Treonina Quinasas/metabolismo , ADN de Cadena Simple , ADN Superhelicoidal/metabolismo , Proteína Quinasa Activada por ADN , Activación Enzimática , Plásmidos , Especificidad por Sustrato
17.
Cancer Genet Cytogenet ; 64(1): 69-74, 1992 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1458453

RESUMEN

In previous work, we established that treatment with melphalan (L-phenylalanine mustard) produced a predominance of A.T-->T.A transversions in the Simian virus 40 (SV40)-based shuttle vector pZ189 during replication in human 293 cells. Mutations were induced with varying doses (4-12 microM) melphalan in the aprt gene of the hemizygous Chinese hamster ovary (CHO) cell line D422 to determine whether a similar mutation spectrum would be observed in an endogenous gene. DNA sequence alterations were determined for 39 spontaneous and 41 melphalan-induced independent mutant clones. Other than a predominance of transversions in both systems, the spectrum of melphalan-induced aprt mutations bears little resemblance to the spectrum observed in the supF gene of the shuttle plasmid pZ189. In aprt, mutations at G.C base pairs (bp) predominated (29 of 41 base substitutions). Significantly enhanced mutagenesis was observed at 5' G-G-C 3' and 5' G-G-C-C 3' sites in the aprt gene. Almost half of the melphalan-induced base substitutions occurred at 5' G-N-C 3' sequences, which are believed to be potential interstrand crosslink sites.


Asunto(s)
Adenina Fosforribosiltransferasa/genética , Análisis Mutacional de ADN , Melfalán/toxicidad , Mutágenos/toxicidad , Mutación , Animales , Secuencia de Bases , Células CHO , Supervivencia Celular , Distribución de Chi-Cuadrado , Cricetinae , Datos de Secuencia Molecular , Pruebas de Mutagenicidad , Reacción en Cadena de la Polimerasa
18.
Environ Mol Mutagen ; 11(4): 461-72, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-2453358

RESUMEN

Previous DNA sequence analysis of bleomycin-induced forward mutations in repackaged lambda phage has suggested SOS-dependent replicative bypass of oxidized apyrimidinic sites as a possible mechanism of mutagenesis. In order to evaluate this hypothesis further, frequencies of mutation to a clear-plaque phenotype were compared for bleomycin-damaged phage grown in various repair-deficient strains of Escherichia coli. Survival of bleomycin-damaged phage was virtually identical in all host strains. Studies in SOS-deficient strains indicated specific requirements for functional recA+ and umuC+ alleles in the generation of the majority of bleomycin-induced mutations, as well as a less stringent requirement for induction of the SOS response by ultraviolet irradiation of the host cells. These results are expected for mutagenesis resulting from apyrimidinic sites. However, the mutation frequency for bleomycin-damaged phage was the same whether the phage were grown in a wild-type strain or in strains deficient in apurinic/apyrimidinic repair endonucleases; this was true even for an nth-nfo-xth- strain lacking all three major apurinic/apyrimidinic endonucleases (endonuclease III, endonuclease IV, and exonuclease III). Likewise, phage grown in an endonuclease IV-overproducing strain showed the same mutation frequency as those grown in wild-type cells. These data suggest that either i) bleomycin-induced mutagenesis results from SOS-dependent bypass of lesions other than apyrimidinic sites or ii) the number of apyrimidinic sites available for SOS processing is virtually independent of the level of apurinic/apyrimidinic endonuclease activity in the cell. It is possible that a fraction of the apyrimidinic sites induced by bleomycin either are intrinsically resistant to repair or undergo secondary reactions that render them resistant.


Asunto(s)
Bacteriófago lambda/efectos de los fármacos , Bleomicina/farmacología , Reparación del ADN , ADN Viral/efectos de los fármacos , Proteínas de Escherichia coli , Escherichia coli/fisiología , Respuesta SOS en Genética , Proteínas Bacterianas/deficiencia , Bacteriófago lambda/genética , ADN Viral/genética , ADN-(Sitio Apurínico o Apirimidínico) Liasa , Desoxirribonucleasa (Dímero de Pirimidina) , Desoxirribonucleasa IV (Fago T4-Inducido) , Endodesoxirribonucleasas/deficiencia , Escherichia coli/enzimología , Exodesoxirribonucleasa V , Exodesoxirribonucleasas/deficiencia , Mutación
19.
Environ Mol Mutagen ; 31(4): 333-9, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9654242

RESUMEN

Previous work showed that a CTAAA sequence in the supF gene of the shuttle plasmid pZ189 was a hotspot for mutagenesis by the aromatic nitrogen mustards melphalan and chlorambucil, and indirect evidence suggested adenine N-3 adducts as premutagenic lesions. In order to characterize the adducts formed at this sequence more directly, a substrate was prepared in which the three adjacent adenines in the CTAAA sequence were 3H-labeled. Following treatment of this substrate with [14C]melphalan, thermolabile adducts were depurinated and analyzed by HPLC. Only a single peak bearing both 3H and 14C label was detected and it coeluted with the single major adduct formed by the reaction of melphalan with free adenine base. Various spectrometric analyses of this species were all consistent with its identification as a monofunctional adenine N-3 adduct of melphalan. There was no evidence for any bifunctional adducts involving the labeled adenines. There was little if any release of the adenine N-3 adduct of melphalan by Escherichia coli AlkA protein, under conditions where 3-methyladenine was quantitatively released. The results support the proposal that monofunctional adenine N-3 adducts are intermediates in the generation of A.T-->T.A and A.T-->C.G transversions by aromatic nitrogen mustards.


Asunto(s)
Melfalán/metabolismo , Melfalán/toxicidad , Mutación , NADH NADPH Oxidorreductasas/farmacología , Secuencia de Bases , Aductos de ADN , Escherichia coli/enzimología
20.
Oncol Res ; 4(1): 7-15, 1992.
Artículo en Inglés | MEDLINE | ID: mdl-1581618

RESUMEN

A method is described which combines alkaline induced DNA unwinding and Southern blotting to measure DNA damage occurring in specific genomic regions. Damage induced by gamma-rays at levels as low as 2 Gy was measured in bulk DNA and in a one megabase region surrounding the actively transcribed oncogene, c-myc, as well as in the inactive alpha-satellite DNA of chromosome 17. Although the unwinding kinetics for bulk DNA were consistent with random strand breakage throughout the genome as a whole, measurements at specific loci indicated that the region encompassing c-myc was at least 2-fold more susceptible to damage than either the bulk of the genome or the alpha-satellite region. The results of this study indicate that the combined alkaline unwinding/Southern blotting assay is a sensitive method for the detection of DNA damage within specific chromatin regions, at biologically relevant doses.


Asunto(s)
Daño del ADN , ADN/efectos de la radiación , Genes myc/efectos de la radiación , Southern Blotting , ADN Satélite , Rayos gamma , Humanos , Concentración de Iones de Hidrógeno , Técnicas In Vitro , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA